Gross Profit Trends Compared: Dr. Reddy's Laboratories Limited vs Amneal Pharmaceuticals, Inc.

Pharma Giants' Profit Battle: Dr. Reddy's vs. Amneal

__timestampAmneal Pharmaceuticals, Inc.Dr. Reddy's Laboratories Limited
Wednesday, January 1, 201444963400075801000000
Thursday, January 1, 201549922600085403000000
Friday, January 1, 201659745500092281000000
Sunday, January 1, 201752617800078356000000
Monday, January 1, 201871640300076304000000
Tuesday, January 1, 201935299700083430000000
Wednesday, January 1, 202062839300094009000000
Friday, January 1, 2021768973000103077000000
Saturday, January 1, 2022784708000113840000000
Sunday, January 1, 2023820565000202972000000
Monday, January 1, 2024163607000000
Loading chart...

Igniting the spark of knowledge

Gross Profit Trends: A Tale of Two Pharmaceutical Giants

In the competitive world of pharmaceuticals, understanding financial trends is crucial. This analysis compares the gross profit trajectories of Dr. Reddy's Laboratories Limited and Amneal Pharmaceuticals, Inc. over a decade, from 2014 to 2023. Dr. Reddy's Laboratories, a major player in the global pharmaceutical market, consistently outperformed Amneal Pharmaceuticals, showcasing a robust growth pattern. By 2023, Dr. Reddy's Laboratories achieved a staggering 167% increase in gross profit compared to 2014, peaking at over 200 billion in 2023. In contrast, Amneal Pharmaceuticals experienced a more modest growth of approximately 82% over the same period, reaching its highest gross profit in 2023. Notably, the data for 2024 is incomplete, highlighting the dynamic nature of financial forecasting. This comparison underscores the importance of strategic financial planning in maintaining competitive advantage in the pharmaceutical industry.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025